A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.

Tianshu Liu

Status: Completed

Conditions: Locally Advanced Gastric Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT02192983

zswy002

Details and patient eligibility

About

This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.

Enrollment: 242 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• more than 2 regional bulky lymph nodes macroscopic tumor type is either the Borrmann type 4 or large type 3 tumor invades adjacent structures (T4b)

Exclusion criteria

• peritoneal metastasis confirmed by CT scan lung metastasis, liver metastasis, pleural effusion, and/or other distant metastasis

Trial design

242 participants in 1 patient group

chemotherapy regimen

Description:

those with XELOX regimen and those with EOX regimen